These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9085173)

  • 1. Characterization of complement C3, C4, and factor B molecules in human bile.
    Sumiyoshi K; Andoh A; Fujiyama Y; Sakumoto H; Bamba T
    J Gastroenterol; 1997 Apr; 32(2):230-5. PubMed ID: 9085173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of complement components (C3, C4, and factor B) in human saliva.
    Andoh A; Fujiyama Y; Kimura T; Uchihara H; Sakumoto H; Okabe H; Bamba T
    J Clin Immunol; 1997 Sep; 17(5):404-7. PubMed ID: 9327340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium butyrate blocks interferon-gamma (IFN-gamma)-induced biosynthesis of MHC class III gene products (complement C4 and factor B) in human fetal intestinal epithelial cells.
    Kitamura K; Andoh A; Inoue T; Amakata Y; Hodohara K; Fujiyama Y; Bamba T
    Clin Exp Immunol; 1999 Oct; 118(1):16-22. PubMed ID: 10540154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of disulphide bonds and localization of interchain linkages in the third (C3) and the fourth (C4) components of human complement.
    Janatova J
    Biochem J; 1986 Feb; 233(3):819-25. PubMed ID: 3707529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential cytokine regulation of complement C3, C4, and factor B synthesis in human intestinal epithelial cell line, Caco-2.
    Andoh A; Fujiyama Y; Bamba T; Hosoda S
    J Immunol; 1993 Oct; 151(8):4239-47. PubMed ID: 8409399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of the third and fourth component of complement (C3, C4) by smooth muscle cells.
    Ueda Y; Nagasawa K; Tsukamoto H; Horiuchi T; Nishizaka H; Ikeda K; Niho Y
    Immunology; 1996 Oct; 89(2):183-8. PubMed ID: 8943712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor B activation products in patients with systemic lupus erythematosus. A marker of severe disease activity.
    Kerr LD; Adelsberg BR; Schulman P; Spiera H
    Arthritis Rheum; 1989 Nov; 32(11):1406-13. PubMed ID: 2818657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies to complement components without the need of their prior purification. II. Antibodies to mouse C3 and C4.
    Kremmer E; Thierfelder S; Felber E; Hoffmann-Fezer G; Wasiliu M
    Hybridoma; 1990 Aug; 9(4):309-17. PubMed ID: 2210776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The phylogeny and evolution of the thioester bond-containing proteins C3, C4 and alpha 2-macroglobulin.
    Dodds AW; Law SK
    Immunol Rev; 1998 Dec; 166():15-26. PubMed ID: 9914899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement components C3, C4, and Bf in six nonhuman primate species.
    McMahan MR
    Lab Anim Sci; 1982 Feb; 32(1):57-9. PubMed ID: 6804713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel ELISA for the assessment of classical pathway of complement activation in vivo by measurement of C4-C3 complexes.
    Zwirner J; Dobos G; Götze O
    J Immunol Methods; 1995 Oct; 186(1):55-63. PubMed ID: 7561148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autolytic fragmentation of complement components C3 and C4 under denaturing conditions, a property shared with alpha 2-macroglobulin.
    Sim RB; Sim E
    Biochem J; 1981 Jan; 193(1):129-41. PubMed ID: 7305917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for non-traditional activation of complement factor C3 during murine liver regeneration.
    Clark A; Weymann A; Hartman E; Turmelle Y; Carroll M; Thurman JM; Holers VM; Hourcade DE; Rudnick DA
    Mol Immunol; 2008 Jun; 45(11):3125-32. PubMed ID: 18452991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and initial characterisation of complement components C3 and C4 of the nurse shark and the channel catfish.
    Dodds AW; Smith SL; Levine RP; Willis AC
    Dev Comp Immunol; 1998; 22(2):207-16. PubMed ID: 9639090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement levels in serum and bile in patients with extra-hepatic biliary tract obstruction.
    Morrison L; Blamey S; Veitch J; Brown I; Whaley K
    J Clin Lab Immunol; 1984 Feb; 13(2):71-4. PubMed ID: 6563089
    [No Abstract]   [Full Text] [Related]  

  • 16. The molecular structure of different polymorphic forms of canine C3 and C4.
    Kay PH; Dawkins RL; Penhale JW
    Immunogenetics; 1985; 21(4):313-9. PubMed ID: 3997206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the haemolytic activity of circulating C1q-C3/C4 complexes.
    Wouters D; Brouwer MC; Daha MR; Hack CE
    Mol Immunol; 2008 Apr; 45(7):1893-9. PubMed ID: 18054386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression, purification, and characterization of third component of complement.
    Lao Z; Wang Y; Mavroidis M; Kostavasili I; Lambris JD
    J Immunol Methods; 1994 Nov; 176(1):127-39. PubMed ID: 7963591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between the human and porcine complement system: a small-angle scattering study of cross immunity and methylamine-induced conformational changes of porcine C3 and C4 proteins.
    Osterberg R; Malmensten B; Boive T; Nilsson U; Stigbrand T; Mortensen K
    Mol Immunol; 1991 Sep; 28(9):959-63. PubMed ID: 1922110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Native conformations of human complement components C3 and C4 show different dependencies on thioester formation.
    Isaac L; Aivazian D; Taniguchi-Sidle A; Ebanks RO; Farah CS; Florido MP; Pangburn MK; Isenman DE
    Biochem J; 1998 Feb; 329 ( Pt 3)(Pt 3):705-12. PubMed ID: 9445402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.